PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: PEPTIDES+ (IMMUNE SUPPORT)
DRUG NAME: LL-37 PEPTIDE

  • FDA Safety Data Sheet not available (experimental peptide).

  • Keshri AK. LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity. Int J Antimicrob Agents. 2025 [PubMed Link]

  • Svensson D. Human antimicrobial/host defense peptide LL-37 may prevent the spread of a local infection through multiple mechanisms: an update. Inflamm Res. 2025 [PubMed Link]

  • Pahar B. Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections. Vaccines (Basel). 2020 [PubMed Link]

  • Fabisiak A. LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity. Pharmacol Rep. 2016 [PubMed Link]

  • Xhindoli D. The human cathelicidin LL-37--A pore-forming antibacterial peptide and host-cell modulator. Biochim Biophys Acta. 2016 [PubMed Link]

  • Chen K. The potentials of short fragments of human anti-microbial peptide LL-37 as a novel therapeutic modality for diseases. Front Biosci (Landmark Ed). 2021 [PubMed Link]

  • Acen EL. Impact of vitamin D status and cathelicidin antimicrobial peptide on adults with active pulmonary TB globally: A systematic review and meta-analysis. PLoS One. 2021 [PubMed Link]

  • Nagaoka I. Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model. Int J Mol Sci. 2020 [PubMed Link]

  • Miao S. Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease. Pharmacol Res. 2024 [PubMed Link]

  • Vera-Cruz A. Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent. Clin Invest Med. 2021 [PubMed Link]

  • Aloul KM. Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Front Immunol. 2022 [PubMed Link]

  • Zhang M. The Critical Role of the Antimicrobial Peptide LL-37/ CRAMP in Protection of Colon Microbiota Balance, Mucosal Homeostasis, Anti-Inflammatory Responses, and Resistance to Carcinogenesis. Crit Rev Immunol. 2019 [PubMed Link]

  • Piktel E, Niemirowicz K, Wnorowska U, Wątek M, Wollny T, Głuszek K, Góźdź S, Levental I, Bucki R. The Role of Cathelicidin LL-37 in Cancer Development. Arch Immunol Ther Exp (Warsz). 2016 [PubMed Link]

  • Memariani M, Memariani H. Antifungal properties of cathelicidin LL-37: current knowledge and future research directions. World J Microbiol Biotechnol. 2023 [PubMed Link]

  • Memariani H, Memariani M. Antibiofilm properties of cathelicidin LL-37: an in-depth review. World J Microbiol Biotechnol. 2023 [PubMed Link]